卵泡抑素(FS)重組蛋白
Recombinant Follistatin (FS)
FST; Activin-binding protein
- 編號RPA391Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預(yù)測分子量31.3kDa
- 實際分子量33kDa(差異分析請參閱說明書)
- 片段與標簽Arg35~Val283 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl, pH8.0, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點8.5
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1046 ¥ 2616 ¥ 5232 ¥ 15696 ¥ 39240
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA391Hu01 | 卵泡抑素(FS)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA391Hu01 | 卵泡抑素(FS)多克隆抗體 | WB; IHC; ICC; IP. |
MAA391Hu23 | 卵泡抑素(FS)單克隆抗體 | WB |
MAA391Hu24 | 卵泡抑素(FS)單克隆抗體 | WB; IHC; ICC; IP. |
MAA391Hu22 | 卵泡抑素(FS)單克隆抗體 | WB |
MAA391Hu21 | 卵泡抑素(FS)單克隆抗體 | WB; IHC; ICC; IP. |
SEA391Hu | 卵泡抑素(FS)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA391Hu | 卵泡抑素(FS)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
BMC Cancer. | Activins and their related proteins in colon carcinogenesis: insights from early and advanced azoxymethane rat models of colon cancer. [pubmed:27835986] |
Journal of cellular physiology | Role of follistatin in muscle and bone alterations induced by gravity change in mice [pubmed:28471505] |
Scientific Reports | Follistatin expressed in mechanically-damaged salivary glands of male mice induces proliferation of CD49f+ cells [Pubmed: 33203957] |
Pathology & Oncology Research | Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status [34867090] |
留言咨詢